These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
550 related articles for article (PubMed ID: 30391537)
1. The role of transferrin receptor in the Helicobacter pylori pathogenesis; L-ferritin as a novel marker for intestinal metaplasia. Hamedi Asl D; Naserpour Farivar T; Rahmani B; Hajmanoochehri F; Emami Razavi AN; Jahanbin B; Soleimani Dodaran M; Peymani A Microb Pathog; 2019 Jan; 126():157-164. PubMed ID: 30391537 [TBL] [Abstract][Full Text] [Related]
2. Gastric epithelial cell proliferation and cagA status in Helicobacter pylori gastritis at different gastric sites. Cabral MM; Oliveira CA; Mendes CM; Guerra J; Queiroz DM; Rocha GA; Rocha AM; Nogueira AM Scand J Gastroenterol; 2007 May; 42(5):545-54. PubMed ID: 17454874 [TBL] [Abstract][Full Text] [Related]
3. [Prevalence of intestinal metaplasia of the gastric cardia and its relation with Helicobacter pylori strains cagA and vacA]. Abdo-Francis JM; Sobrino-Cossío S; Bernal-Sahagún F; Hernández-Guerrero A Cir Cir; 2010; 78(4):315-21. PubMed ID: 21167097 [TBL] [Abstract][Full Text] [Related]
4. Key importance of the Helicobacter pylori adherence factor blood group antigen binding adhesin during chronic gastric inflammation. Prinz C; Schöniger M; Rad R; Becker I; Keiditsch E; Wagenpfeil S; Classen M; Rösch T; Schepp W; Gerhard M Cancer Res; 2001 Mar; 61(5):1903-9. PubMed ID: 11280745 [TBL] [Abstract][Full Text] [Related]
5. The crosstalk between H. pylori virulence factors and the PD1:PD-L1 immune checkpoint inhibitors in progression to gastric cancer. Aydın EM; Demir TD; Seymen N; Said SS; Oktem-Okullu S; Tiftikci A; Cicek B; Tokat F; Tozun N; Ince U; Sezerman U; Sayi-Yazgan A Immunol Lett; 2021 Nov; 239():1-11. PubMed ID: 34363898 [TBL] [Abstract][Full Text] [Related]
6. Study of p53 immunostaining in the gastric epithelium of cagA-positive and cagA-negative Helicobacter pylori gastritis. Teh M; Tan KB; Seet BL; Yeoh KG Cancer; 2002 Aug; 95(3):499-505. PubMed ID: 12209741 [TBL] [Abstract][Full Text] [Related]
7. Atrophic gastritis and intestinal metaplasia in Helicobacter pylori infection: the role of CagA status. Sozzi M; Valentini M; Figura N; De Paoli P; Tedeschi RM; Gloghini A; Serraino D; Poletti M; Carbone A Am J Gastroenterol; 1998 Mar; 93(3):375-9. PubMed ID: 9517643 [TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori CagA status, mucosal oxidative damage and gastritis phenotype: a potential pathway to cancer? Farinati F; Cardin R; Russo VM; Busatto G; Franco M; Rugge M Helicobacter; 2003 Jun; 8(3):227-34. PubMed ID: 12752735 [TBL] [Abstract][Full Text] [Related]
9. Antral-type mucosa in the gastric incisura, body, and fundus (antralization): a link between Helicobacter pylori infection and intestinal metaplasia? Xia HH; Kalantar JS; Talley NJ; Wyatt JM; Adams S; Chueng K; Mitchell HM Am J Gastroenterol; 2000 Jan; 95(1):114-21. PubMed ID: 10638568 [TBL] [Abstract][Full Text] [Related]
10. Role of Helicobacter pylori in gastric carcinoma. Prabhu SR; Amrapurkar AD; Amrapurkar DN Natl Med J India; 1995; 8(2):58-60. PubMed ID: 7735060 [TBL] [Abstract][Full Text] [Related]
11. The expression level of TRAF1 in human gastric mucosa is related to virulence genotypes of Helicobacter pylori. Wang F; Bu G; Feng Q; Liu Z; Xu C; Shen S; Yuan Y Scand J Gastroenterol; 2014 Aug; 49(8):925-32. PubMed ID: 24852885 [TBL] [Abstract][Full Text] [Related]
12. Role of vacuolating cytotoxin VacA and cytotoxin-associated antigen CagA of Helicobacter pylori in the progression of gastric cancer. Ki MR; Hwang M; Kim AY; Lee EM; Lee EJ; Lee MM; Sung SE; Kim SH; Lee HS; Jeong KS Mol Cell Biochem; 2014 Nov; 396(1-2):23-32. PubMed ID: 25038872 [TBL] [Abstract][Full Text] [Related]
13. Up-regulation of inducible nitric oxide synthase in Helicobacter pylori-associated gastritis may represent an increased risk factor to develop gastric carcinoma of the intestinal type. Rieder G; Hofmann JA; Hatz RA; Stolte M; Enders GA Int J Med Microbiol; 2003 Dec; 293(6):403-12. PubMed ID: 14760971 [TBL] [Abstract][Full Text] [Related]
14. Cyclooxigenase-2 and osteopontin in gastric pre-neoplastic lesions in relation to H-pylori infection and grade of inflammation. Benedetti I; Hoyos J; Barrios L Rev Esp Patol; 2020; 53(2):79-87. PubMed ID: 32199598 [TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori regulates TLR4 and TLR9 during gastric carcinogenesis. Wang TR; Peng JC; Qiao YQ; Zhu MM; Zhao D; Shen J; Ran ZH Int J Clin Exp Pathol; 2014; 7(10):6950-5. PubMed ID: 25400780 [TBL] [Abstract][Full Text] [Related]
16. Oxidative damage of the gastric mucosa in Helicobacter pylori positive chronic atrophic and nonatrophic gastritis, before and after eradication. Iacopini F; Consolazio A; Bosco D; Marcheggiano A; Bella A; Pica R; Paoluzi OA; Crispino P; Rivera M; Mottolese M; Nardi F; Paoluzi P Helicobacter; 2003; 8(5):503-12. PubMed ID: 14535997 [TBL] [Abstract][Full Text] [Related]
17. Topographic expression of MUC5AC and MUC6 in the gastric mucosa infected by Helicobacter pylori and in associated diseases. Marques T; David L; Reis C; Nogueira A Pathol Res Pract; 2005; 201(10):665-72. PubMed ID: 16325508 [TBL] [Abstract][Full Text] [Related]
18. [Effect of Helicobacter pylori infection and eradication on proliferative kinetics of the gastric mucosa]. Unger Z; Prónai L; Szaleczky E; Zágoni T; Molnár B; Tulassay Z Orv Hetil; 2000 Dec; 141(50):2695-700. PubMed ID: 11189675 [TBL] [Abstract][Full Text] [Related]
19. Downregulated regulatory T cell function is associated with increased peptic ulcer in Helicobacter pylori-infection. Bagheri N; Shirzad H; Elahi S; Azadegan-Dehkordi F; Rahimian G; Shafigh M; Rashidii R; Sarafnejad A; Rafieian-Kopaei M; Faridani R; Tahmasbi K; Kheiri S; Razavi A Microb Pathog; 2017 Sep; 110():165-175. PubMed ID: 28666843 [TBL] [Abstract][Full Text] [Related]
20. Compartment theory in Helicobacter pylori-associated gastric carcinogenesis. Tseng HH; Hsu PI; Chen HC; Lai KH; Lo GH; Lo CC; Chou NH; Mok KT; Chen IS; Chou NH; Yang HB; Liu L; Hsu PN Anticancer Res; 2003; 23(4):3223-9. PubMed ID: 12926056 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]